Study to Evaluate the Prospective Payment System (STEPPS™)

Amgen

Status: Completed

Conditions: Chronic Kidney Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT01717989

20080234

Details and patient eligibility

About

To describe trends in treatment patterns of Small Dialysis Organizations (SDOs) prior to and during the implementation of the Centers for Medicare and Medicaid Services' (CMS') policy [End Stage Renal Disease (ESRD) Prospective Payment System (PPS)] to bundle reimbursement for all dialysis services. Specifically, to describe CMS ESRD PPS quality performance measures for dialysis centers over time.

Enrollment: 2,248 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Patient Inclusion Criteria:

• Adults ≥ 18 years of age who have given written informed consent
• Documented physician diagnosis of ESRD requiring dialysis and receiving care at a participating dialysis center
• Undergoing dialysis on the dialysis schedule assigned to the site

Patient Exclusion Criteria:

• Patients will be ineligible for the study if they do not consent to have their data collected for research purposes.

Trial design

2,248 participants in 1 patient group

Cohort

Description:

Patients with end-stage renal disease (ESRD) treated at small dialysis organizations (SDOs).